Dr Alberto Ospina Stella

Kirby Institute for Infection and Immunity, Sydney, Australia

Dr. Alberto Ospina Stella is an experienced medical scientist at the Kirby Institute for Infection and Immunity and an Associate Lecturer at the University of New South Wales in Sydney, Australia.

With expertise spanning infection biology, immunovirology, and vaccinology, Dr. Stella’s collaborative research focuses on characterizing host immune responses and their role in the diagnosis, prevention, manifestation, and treatment of viral infections. His work has directly contributed to the development of both preclinical and clinically relevant vaccines and immunotherapeutics, with publications cited by the CDC and public health advisory groups in multiple countries.

Dr. Stella’s scientific journey began in Germany, where he completed formal training in molecular biotechnology (B.Sc.) and molecular medicine (M.Sc.), before earning his Ph.D from the University of New South Wales for his research on HIV host–pathogen interactions to advance novel host-directed antiviral therapy strategies.

During the COVID-19 pandemic, Dr. Stella developed novel reagents and high-throughput assays that enabled the rapid characterization of emerging SARS-CoV-2 viral variants and their evolving resistance to vaccines and monoclonal antibodies. Through collaborative functional genomic studies, he has also contributed to identifying key host factors involved in viral entry, tropism, and replication. His recent work has expanded to explore molecular medicine solutions targeting other respiratory viruses, including RSV and Influenza.

 

Updated 18 June 2025